Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics Previous close 46.11
Open 45.71
Day range 43.69 45.79
52-week range 38.00 64.00
Off day high −4.37%
Off 52-week high −31.59%
Volume 13.00
Avg. volume (3M) 585
Market cap —
EPS (TTM) —
Forward P/E —
P/E ratio (TTM) —
Dividend yield —
Beta (5Y) —
Shares outstanding —
Short interest —
Earnings date Aug 3, 2026 (est.)
Analyst target —
Profit margin —
No recent coverage in the 4Search index.
From articles in the 4Search news index.
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facil…
From Wikipedia , CC BY-SA 4.0
Earnings
Next report: Mon, Aug 3, 2026 (estimated)
Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).
Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).
Not eligible for Growth tech (U.S. technology stocks only).
Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).
A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.
Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use .